The Current Landscape and Future Prospects of Vaccine Manufacturing in Africa: Challenges, Innovations, and Opportunities: A Narrative Review

Background and Aims: Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property. This review evaluates African vaccine manufacturing capacity, region‐specific limitations, and highlights significant innovations and policy alternatives to promote vaccine autonomy and equitable public health results.

Methods: A comprehensive narrative evaluation of the literature was done. We obtained prior papers from WHO publications, CDC publications, Google Scholar, Elsevier, PubMed, and EBSCOhost. The assessment examines the current status and future prospects of vaccine manufacturing in Africa, emphasizing obstacles, innovations, and possibilities.

Results: Africa's vaccine manufacturing capacity is constrained by limited production infrastructure, a shortage of skilled personnel, and inadequate technical resources. These challenges are compounded by financial constraints, heavy reliance on donor support, and restricted access to technology transfer. In remote regions, regulatory fragmentation and weak cold chain infrastructure further hinder vaccine distribution. Promising innovations such as mRNA platforms, heat‐stable formulations, and microarray patches offer potential breakthroughs, but progress in scaling up manufacturing remains slow despite international partnerships and funding support. To achieve vaccine self‐sufficiency, Africa must strengthen its research ecosystem, build a skilled workforce, and expand domestic manufacturing capabilities.

Conclusion: Africa's vaccine manufacturing capacity is at an important phase, requiring coordinated efforts to overcome long‐standing barriers. Investment in local vaccine facilities, skilled personnel development, and strong regulatory framework are essential. Strengthening international partnerships while fostering local innovations will lead to self‐reliance. Emphasis on One Health approaches can enhance disease surveillance and control. Adequate funding and political will are indispensable for sustained progress.